Mirjam K Rommers

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Preventing adverse drug events in hospital practice: an overview
    Mirjam K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, The Netherlands
    Pharmacoepidemiol Drug Saf 16:1129-35. 2007
  2. ncbi A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands
    Mirjam K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
    Drug Saf 34:233-42. 2011
  3. ncbi Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
    Mirjam K Rommers
    Hospital Pharmacy Midden Brabant TweeSteden Hospital and St Elisabeth Hospital, Tilburg, The Netherlands
    Crit Care 10:R93. 2006
  4. ncbi Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event
    M K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Qual Saf Health Care 19:e35. 2010

Detail Information

Publications4

  1. ncbi Preventing adverse drug events in hospital practice: an overview
    Mirjam K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, The Netherlands
    Pharmacoepidemiol Drug Saf 16:1129-35. 2007
    ..Moreover, two promising CDSS are discussed in more detail, namely computer-based monitoring systems and information systems which link laboratory and pharmacy data...
  2. ncbi A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands
    Mirjam K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
    Drug Saf 34:233-42. 2011
    ..In the Netherlands there are some basic CDSS within CPOE systems, but there is not much experience with sophisticated systems. We have recently developed a more advanced CDSS, a computerized adverse drug event alerting system (ADEAS)...
  3. ncbi Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
    Mirjam K Rommers
    Hospital Pharmacy Midden Brabant TweeSteden Hospital and St Elisabeth Hospital, Tilburg, The Netherlands
    Crit Care 10:R93. 2006
    ..The objective of this study is to compare the anti-Xa activity of dalteparin after subcutaneous administration in ICU patients with and without subcutaneous oedema...
  4. ncbi Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event
    M K Rommers
    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Qual Saf Health Care 19:e35. 2010
    ..Fortunately, a substantial part of ADEs is preventable, and computerised physician order entry with a sophisticated clinical decision support system may be used to reach this goal...